Pharmabiz
 

GSCR to conduct GCP training course in Mumbai

Our Bureau, MumbaiFriday, February 3, 2006, 08:00 Hrs  [IST]

Global Spectrum Clinical Research (GSCR) will be conducting a Good Clinical Practice (GCP) training course on February 11th and 12th, 2006 at Park Sarovar, Royal Palms, Mumbai. The aim of the course is to educate the medical fraternity with knowledge and guidelines for conducting and participating in clinical research. "The focus would be on the standard for the design, conduct, performance, monitoring, auditing, recording, analysis, and reporting of the clinical trials. ACRP would endorse the course and the course fee is Rs 2500," said the GSCR sources. "With product patents regime in place, India is identified as a major resource center for conducting clinical trials and data management services. It is widely recognised as a nation, which has the ability to offer unique opportunities for conducting clinical trials. Increased regulatory control and its acceptance of the ICH guidelines for GCP have further enhanced India's reputation as a place to conduct clinical trials. Therefore, the course with its renowned faculty members will definitely help clinical trials investigators," said Dr. Viral Shah, medical director, GSCR. The faculty members conducting the course include, Dr. G.A. Fleming, ex- US FDA reviewer and supervisory medical officer; Dr. Ram Shrivastava, research director, GSCR, Mumbai and founder member of the centre in New York which has conducted over 500 clinical trials; Dr. Mike Pontecorvo, who has lead clinical research teams for over 15 years; Dr. Rajkumar, former president at R&D, Ranbaxy and Kim Foglia, vice- president, Glaxo Smith Kline; Dr. Vidyaguari Baliga and Dr. Dave Nach, having over 15 years of experience in clinical research. GSCR is a study/ site management organisation (SMO), first of its kind in the country offering a wide range of consulting and research services to pharmaceutical companies, and contract research organisations. It emphasises on scientific excellence, in order to maintain the highest possible standards to produce results that can withstand the most rigorous review.

 
[Close]